AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29378515 — intervention group
Group type: COMPARATOR
Intervention: Active control (BAT) - combination of educational classes, sham cognitive training, and balanced and tone exercises
Number of subjects: 3
Study 27517680 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 230
Study 27517680 — intervention group
Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 230
Study 25784665 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/kg/min) during hyperglycemia (∼12 mmol/L)
Number of subjects: 10
Study 25784665 — intervention group
Group type: COMPARATOR
Intervention: Placebo during hyperglycemia (∼12 mmol/L)
Number of subjects: 10
Study 25784665 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/kg/min) during euglycemia (∼6 mmol/L)
Number of subjects: 10
Study 25784665 — intervention group
Group type: COMPARATOR
Intervention: Placebo during euglycemia (∼6 mmol/L)
Number of subjects: 10
Study 23833850 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol total intravenous anesthesia (TIVA)
Number of subjects: 36
Study 23833850 — intervention group
Group type: COMPARATOR
Intervention: Desflurane-thiopental anesthesia
Number of subjects: 36
Study 21122265 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week traditional exercise programme with supplementary whole-body vibration (WBV)
Number of subjects: 30
Study 21122265 — intervention group
Group type: COMPARATOR
Intervention: Control group performing the same physical activity programme without vibration training
Number of subjects: 30
Study 18254806 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid- and creatine-containing formulation
Number of subjects: 0
Study 16361300 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg
Number of subjects: 40
Study 16361300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 14635469 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 13
Study 14635469 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 mg)
Number of subjects: 13
Study 14635469 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine + Terbutaline
Number of subjects: 13
Study 14635469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 10953120 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-J stent
Number of subjects: 670
Study 10953120 — intervention group
Group type: COMPARATOR
Intervention: No stenting
Number of subjects: 670
Study 9208508 — intervention group
Group type: EXPERIMENTAL
Intervention: Boosting doses of rabies vaccine
Number of subjects: 91
Study 9208508 — intervention group
Group type: COMPARATOR
Intervention: 5-doses of rabies vaccine
Number of subjects: 91
Study 1469179 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind brush (BB) sampling
Number of subjects: 37
Study 1469179 — intervention group
Group type: COMPARATOR
Intervention: Plugged telescoping catheter via fiberoptic bronchoscopy (PTC‐FB) sampling
Number of subjects: 37
Study 6378354 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer Factor (TF)
Number of subjects: 171
Study 6378354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study 31067999 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection site cooling
Number of subjects: 14
Study 31067999 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection site warming
Number of subjects: 14
Study 31067999 — intervention group
Group type: COMPARATOR
Intervention: Control (no warming or cooling)
Number of subjects: 14
Study 28612500 — intervention group
Group type: EXPERIMENTAL
Intervention: Image J software for measuring ulcer area
Number of subjects: 31
Study 26494609 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer use and class competition over 12 weeks
Number of subjects: 1162
Study 23378247 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (maintain two train-of-four (TOF) counts)
Number of subjects: 120
Study 23378247 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (maintain a T(1)/Tc of 0.5)
Number of subjects: 120
Study 23378247 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (maintain a T(2)/Tc of 0.5)
Number of subjects: 120
Study 23378247 — intervention group
Group type: COMPARATOR
Intervention: Group D (no NMB)
Number of subjects: 120
Study 22005159 — intervention group
Group type: EXPERIMENTAL
Intervention: Ho:YAG laser urethrotomy (15 W; 1,200‐1,400 mJ; 8‐12 Hz)
Number of subjects: 51
Study 22005159 — intervention group
Group type: COMPARATOR
Intervention: Cold-knife urethrotomy
Number of subjects: 51
Study 20027435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold lateral and warm vertical condensation of gutta-percha with Sealapex or Diaket sealers, post space prepared either individually or simultaneously.
Number of subjects: 64
Study 20027435 — intervention group
Group type: COMPARATOR
Intervention: Control group (positive and negative controls).
Number of subjects: 64
Study 17085633 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention (5-week manualized intervention)
Number of subjects: 3
Study 14751338 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepartricin (40 mg daily)
Number of subjects: 26
Study 14751338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 15321608 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine wedged position
Number of subjects: 40
Study 15321608 — intervention group
Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 40
Study 9555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.1875, 0.375, and 0.5625 mg)
Number of subjects: 9
Study 9555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (7.5, 15, and 22.5 mg)
Number of subjects: 9
Study 9555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Quazepam (15, 30, and 45 mg)
Number of subjects: 9
Study 9555600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7912819 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (AMI) 50 mg for 2 weeks, then 100 mg for 4 weeks
Number of subjects: 40
Study 7912819 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine (FLU) 2 mg for 2 weeks, then 4 mg for 4 weeks
Number of subjects: 40
Study 2692153 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 121
Study 2692153 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 121
Study 2692153 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (for atypical pneumonias and opportunistic infections)
Number of subjects: 121
Study 790549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 0
Study 790549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31789457 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread therapy (PLLA) combined with minoxidil
Number of subjects: 27
Study 31789457 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil alone
Number of subjects: 27
Study 30805623 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet (300 g/kg)
Number of subjects: 320
Study 30805623 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet with xylanase (2,500 U/kg)
Number of subjects: 320
Study 30805623 — intervention group
Group type: COMPARATOR
Intervention: Control diet (DDGS free)
Number of subjects: 320
Study 30805623 — intervention group
Group type: COMPARATOR
Intervention: Control diet with xylanase (2,500 U/kg)
Number of subjects: 320
Study 30805623 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat DDGS diet
Number of subjects: 320
Study 26961522 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity glass-ionomer sealants
Number of subjects: 157
Study 26961522 — intervention group
Group type: COMPARATOR
Intervention: Glass-carbomer sealants
Number of subjects: 157
Study 26961522 — intervention group
Group type: COMPARATOR
Intervention: Resin sealants
Number of subjects: 157
Study 26039907 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan slurry
Number of subjects: 26
Study 26039907 — intervention group
Group type: COMPARATOR
Intervention: Control slurry
Number of subjects: 26
Study 21949091 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized caregiver training program
Number of subjects: 120
Study 21949091 — intervention group
Group type: COMPARATOR
Intervention: Control group (information about community-based resources)
Number of subjects: 120
Study 21719636 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping With and Caring for Infants With Special Needs (COPCA)
Number of subjects: 46
Study 21719636 — intervention group
Group type: COMPARATOR
Intervention: Traditional infant physical therapy (TIP)
Number of subjects: 46
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir
Number of subjects: 9
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral valganciclovir
Number of subjects: 9
Study 19704173 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 9
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent viral load at day 21
Number of subjects: 9
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed ganciclovir resistance mutation
Number of subjects: 9
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with confirmed CMV resistance mutations
Number of subjects: 9
Study 19704173 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed ganciclovir-resistant UL97 mutants
Number of subjects: 9
Study 16395750 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone with rapid tapering (medrol dose-pack)
Number of subjects: 50
Study 16395750 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone 100 mg, given intramuscularly
Number of subjects: 50
Study 15684846 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality treatment consisting of aromatherapy, footsoak, and reflexology
Number of subjects: 20
Study 11514044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training interventions (memory, reasoning, and speed of information processing)
Number of subjects: 2832
Study 9414079 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate meal three hours before exercise and a carbohydrate‐electrolyte solution during exercise (M + C)
Number of subjects: 10
Study 9414079 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate‐electrolyte solution during exercise (P + C)
Number of subjects: 10
Study 9414079 — intervention group
Group type: COMPARATOR
Intervention: Placebo three hours before exercise and placebo during exercise (P + P)
Number of subjects: 10
Study 8119423 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival injection of betamethasone (Betnesol, Glaxo)
Number of subjects: 246
Study 3311690 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of famotidine
Number of subjects: 6
Study 3311690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 29893677 — intervention group
Group type: EXPERIMENTAL
Intervention: MiECC (priming volume 550mL)
Number of subjects: 72
Study 29893677 — intervention group
Group type: EXPERIMENTAL
Intervention: closeECC (priming volume 1250mL)
Number of subjects: 72
Study 29893677 — intervention group
Group type: COMPARATOR
Intervention: openECC (priming volume 1250mL)
Number of subjects: 72
Study 27128220 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing Angry Birds on a hand-held computer
Number of subjects: 200
Study 27128220 — intervention group
Group type: COMPARATOR
Intervention: Low-tech distraction by a nurse (singing, reading, blowing bubbles, playing with puppets)
Number of subjects: 200
Study 27128220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 25310525 — intervention group
Group type: EXPERIMENTAL
Intervention: ECLA-F (face-to-face intervention)
Number of subjects: 257
Study 25310525 — intervention group
Group type: EXPERIMENTAL
Intervention: ECLA-T (telephone intervention)
Number of subjects: 257
Study 25310525 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 257
Study 23639675 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic tablets
Number of subjects: 192
Study 23639675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 20604675 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic sclerosis patients
Number of subjects: 50
Study 20604675 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study 18156089 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 6093
Study 18156089 — intervention group
Group type: COMPARATOR
Intervention: Glycopeptides or β-lactams
Number of subjects: 6093
Study 16759313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diet and exercise intervention
Number of subjects: 522
Study 16759313 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 522
Study 15748067 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits from trained personnel
Number of subjects: 480
Study 10802992 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic course of the Army Reserve critical care nursing residency program
Number of subjects: 27
Study 10802992 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 nurses)
Number of subjects: 27
Study 8606262 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban (MK-383) administered in three sequential dose panels: bolus doses of 5, 10, and 10 microg/kg and continuous infusion doses of 0.05, 0.10, and 0.15 microg/kg per min for 16 to 24 hours
Number of subjects: 93
Study 8606262 — intervention group
Group type: COMPARATOR
Intervention: Placebo (heparin and aspirin only)
Number of subjects: 93
Study 7933251 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical carotid artery stenosis (80% to 99% diameter)
Number of subjects: 197
Study 7933251 — intervention group
Group type: COMPARATOR
Intervention: Noncritical carotid artery stenosis
Number of subjects: 197
Study 7933251 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical carotid artery stenosis with APO
Number of subjects: 197
Study 7933251 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical carotid artery stenosis
Number of subjects: 197
Study 3279857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion (three doses)
Number of subjects: 10
Study 3279857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3279857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion
Number of subjects: 10
Study 31599602 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys Town In‐Home Family Services (IHFS) program for families
Number of subjects: 300
Study 31599602 — intervention group
Group type: COMPARATOR
Intervention: Services as usual comparison group
Number of subjects: 300
Study 29766413 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque disclosure with subsequent oral hygiene (tooth brushing with prior plaque disclosure)
Number of subjects: 20
Study 29766413 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral hygiene (tooth brushing)
Number of subjects: 20
Study 28092416 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (360 ELISA units/dose) administered in three different schedules: (i) 0,1,2 months; (ii) 0,1,6 months; (iii) 0,1,12 months
Number of subjects: 144
Study 28092416 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (0,1,2 months)
Number of subjects: 144
Study 28092416 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (0,1,6 months)
Number of subjects: 144
Study 28092416 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (0,1,12 months)
Number of subjects: 144
Study 28092416 — intervention group
Group type: COMPARATOR
Intervention: Overall analysis
Number of subjects: 144
Study 25403522 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal self‐acupressure plus standard treatment options
Number of subjects: 100
Study 25403522 — intervention group
Group type: COMPARATOR
Intervention: Standard constipation treatment options
Number of subjects: 100
Study 23298339 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF/FTC
Number of subjects: 80
Study 23298339 — intervention group
Group type: COMPARATOR
Intervention: ZDV/3TC
Number of subjects: 80
Study 21639659 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic Alliance video
Number of subjects: 105
Study 21639659 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential Acceptance video
Number of subjects: 105
Study 21639659 — intervention group
Group type: COMPARATOR
Intervention: Alliance video
Number of subjects: 105
Study 21639659 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 105
Study 17412717 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Internet-based intervention for self-care (LSE group)
Number of subjects: 64
Study 17412717 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Internet-based intervention for self-care (HSE group)
Number of subjects: 64
Study 17412717 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-targeted self-care areas (both groups)
Number of subjects: 64
Study 17412717 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy levels (both groups)
Number of subjects: 64
Study 16842477 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 405
Study 16842477 — intervention group
Group type: COMPARATOR
Intervention: Oral agents
Number of subjects: 405
Study 14634491 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyenylphosphatidylcholine
Number of subjects: 789
Study 14634491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 789
Study 10617985 — intervention group
Group type: EXPERIMENTAL
Intervention: Algae-produced high-DHA triacylglycerol (170-260 mg/d)
Number of subjects: 24
Study 10617985 — intervention group
Group type: EXPERIMENTAL
Intervention: High-DHA eggs (170-260 mg/d)
Number of subjects: 24
Study 10617985 — intervention group
Group type: EXPERIMENTAL
Intervention: High-DHA, low-eicosapentaenoic acid marine oil (170-260 mg/d)
Number of subjects: 24
Study 10617985 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (Control group)
Number of subjects: 24
Study 7759034 — intervention group
Group type: COMPARATOR
Intervention: hydroxyethylsalicyclate gel
Number of subjects: 113
Study 2182448 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral verapamil treatment
Number of subjects: 64
Study 2182448 — intervention group
Group type: COMPARATOR
Intervention: Nonverapamil group
Number of subjects: 64
Study 372063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg twice daily)
Number of subjects: 60
Study 372063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 372063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 60
Study 31657885 — intervention group
Group type: EXPERIMENTAL
Intervention: LabSafety application
Number of subjects: 316
Study 31657885 — intervention group
Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 316
Study 31657885 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 316
Study 31157627 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of red blood cells
Number of subjects: 0
Study 31157627 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion practice guided by tissue oximeter and viscoelastic tests
Number of subjects: 0
Study 31157627 — intervention group
Group type: COMPARATOR
Intervention: Transfusion triggers for other blood products
Number of subjects: 0
Study 28854266 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 2394
Study 28854266 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 2394
Study 28854266 — intervention group
Group type: COMPARATOR
Intervention: Combined analysis of on-pump and off-pump CABG
Number of subjects: 2394
Study 28854266 — intervention group
Group type: COMPARATOR
Intervention: Logistic EuroSCORE
Number of subjects: 2394
Study 28854266 — intervention group
Group type: COMPARATOR
Intervention: KCH score
Number of subjects: 2394
Study 28854266 — intervention group
Group type: COMPARATOR
Intervention: Excluding female sex from risk models
Number of subjects: 2394
Study 25664394 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOX + cetuximab
Number of subjects: 453
Study 25664394 — intervention group
Group type: COMPARATOR
Intervention: FLOX
Number of subjects: 453
Study 23694982 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vinorelbine at 60 mg/m²
Number of subjects: 39
Study 23694982 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin at 40 mg/m²
Number of subjects: 39
Study 21866183 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet intervention
Number of subjects: 118
Study 21866183 — intervention group
Group type: COMPARATOR
Intervention: Usual diet control (UC)
Number of subjects: 118
Study 19843377 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (vitamins E and C); n = 10
Number of subjects: 20
Study 19843377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebos); n = 10
Number of subjects: 20
Study 16960440 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol (50 microg)
Number of subjects: 20
Study 16960440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15533340 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid luteal phase biopsy (days 21-22)
Number of subjects: 847
Study 15533340 — intervention group
Group type: EXPERIMENTAL
Intervention: Late luteal phase biopsy (days 26-27)
Number of subjects: 847
Study 11422131 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 800 microg/daily for 6 months
Number of subjects: 28
Study 11422131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9491590 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure attachment style
Number of subjects: 0
Study 9491590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambivalent attachment style
Number of subjects: 0
Study 9491590 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidant attachment style
Number of subjects: 0
Study 7906536 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 20 micrograms kg‐1
Number of subjects: 80
Study 7906536 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 30 micrograms kg‐1
Number of subjects: 80